MacroGenics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.About MGNX
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.
CEOScott E. Koenig
CEOScott E. Koenig
Employees339
Employees339
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2000
Founded2000
Employees339
Employees339
MGNX Key Statistics
Market cap976.26M
Market cap976.26M
Price-Earnings ratio-100.07
Price-Earnings ratio-100.07
Dividend yield—
Dividend yield—
Average volume760.21K
Average volume760.21K
High today$15.89
High today$15.89
Low today$15.32
Low today$15.32
Open price$15.64
Open price$15.64
Volume53.76K
Volume53.76K
52 Week high$21.88
52 Week high$21.88
52 Week low$4.29
52 Week low$4.29
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%